Published September 18, 2007 | Version v1
Journal article

Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer

  • 1. Department of Radiation Oncology, Val d'Aurelle Cancer Institute, Montpellier (France)
  • 2. Radiophysics Unit, Val d'Aurelle Cancer Institute, Montpellier (France)
  • 3. Department of Head and Neck Surgery, University Hospital Gui De Chauliac, Montpellier (France)

Description

To compare non coplanar field (NCF) with coplanar field (CF) -intensity-modulated radiotherapy (IMRT) planning for ethmoid cancer. Seven patients treated with NCF IMRT for ethmoid cancer were studied. A CF IMRT optimization was prepared with the same constraints as for the NCF treatment. The maximum point doses (D max) obtained for the different optic pathway structures (OPS) should differ no more than 3% from those achieved with the NCF IMRT plan. The distribution of the dose in the target volume and in the critical structures was compared between the two techniques, as well as the Conformity (CI) and the Homogeneity Indexes (HI) in the target volume. We noted no difference between the two techniques in the OPS for the D1, D2, and D5%, in the inner ear and controlateral lens for the average Dmax, in the temporo-mandibular joints for the average mean dose, in the cord and brainstem for the average D1%. The dose-volume histograms were slightly better with the NCF treatment plan for the planning target volume (PTV) with a marginally better HI but no impact on CI. We found a great improvement in the PTV coverage with the CF treatment plan for two patients with T4 tumors. IMRT is one of the treatment options for ethmoid cancer. The PTV coverage is optimal without compromising the protection of the OPS. The impact of non coplanar versus coplanar set up is very slight

Availability note (English)

Available from http://dx.doi.org/10.1186/1748-717X-2-35; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072954

Additional details

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
2
Journal Page Range
p. 35
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47029271
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
AUDITORY ORGANS; NEOPLASMS; PATIENTS; PLANNING; RADIOTHERAPY; SINUSES
Descriptors DEC
BODY; CAVITIES; DISEASES; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; SENSE ORGANS; THERAPY

Optional Information

Copyright
Copyright (c) 2007 Serre et al
Notes
PMCID: PMC2072954; PUBLISHER-ID: 1748-717X-2-35; PMID: 17877793; OAI: oai:pubmedcentral.nih.gov:2072954; licensee BioMed Central Ltd.